Carnegie Mellon University
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 7, 2025), Carnegie Mellon University reported 5 stock positions worth $154.6 million. Its top holding was Duolingo (DUOL) at 78.2% of the portfolio, followed by Invesco QQQ Trust Series 1 (QQQ, 21.8%) and Innsuites Hospitality Trust (IHT, 0.0%). Compared with Q1 2025, it sold out of 1, added to 1 and reduced 2. The biggest buy was Invesco QQQ Trust Series 1 (QQQ, shares +0%) and the biggest sale an exit from PDD (PDD).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $154.6M (Q2 2025)
- SEC Filing
- 0000898432-25-000544 ↗ filed Aug 7, 2025
Holdings Value
Holdings 5 stocks · $154.6M
| DUOL Duolingo | 78.19% | 294,814 | $120.9M | Reduce -4.8% |
| QQQ Invesco QQQ Trust Series 1 | 21.78% | 61,039 | $33.7M | Add +0.1% |
| IHT Innsuites Hospitality Trust | 0.01% | 10,000 | $23K | No change |
| LONGEVITY HEALTH HLDGS INC | 0.01% | 4,482 | $11K | Reduce -96.7% |
| PREDICTIVE ONCOLOGY INC | 0.01% | 10,358 | $9K | No change |
Portfolio Sells Q1 2025 → Q2 2025
| PDD PDD Holdings Inc. | Sold out | 0.00% | −3.24 |
| LONGEVITY HEALTH HLDGS INC | Reduce -96.7% | 0.01% | −0.01 |
| DUOL Duolingo | Reduce -4.8% | 78.19% | +3.62 |
Portfolio Buys Q1 2025 → Q2 2025
| QQQ Invesco QQQ Trust Series 1 | Add +0.1% | 21.78% | −0.37 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |